Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Fortner

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Drug Intelligence & Clinical Pharmacy|May 1, 1985
Cisplatin nephrotoxicity: a summary of preventative interventionsR S Finley, C L Fortner, W R Grove
American Journal of Hospital Pharmacy|September 1, 1977
High-dose methotrexate with folinic acid rescueJ F Bender, W R Grove, C L Fortner
American Journal of Hospital Pharmacy|June 1, 1975
Fat emulsion vehicle for intravenous administration of an aqueous insoluble drugC L Fortner, W R Grove, D Bowie, et al.
Archives of Internal Medicine|April 1, 1980
Meperidine for the treatment of shaking chills and feverL C Burks, J Aisner, C L Fortner, et al.
Clinical Pharmacy|July 1, 1982
Rifampin and cloxacillin in the reduction of Staphylococcus aureus colonizationR S Finley, S C Schimpff, C L Fortner, et al.
Journal of the American Pharmaceutical Association|January 1, 1973
Allopurinol-mercaptopurine interactionA M Weissman, D G Christian, W A Cornelis, et al.
The Journal of Infectious Diseases|December 1, 1974
Cytosine arabinoside for localized herpes zoster in patients with cancer: failure in a controlled trialS C Schimpff, C L Fortner, W H Greene, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Hypersensitivity reactions to teniposide (VM-26): an analysisP J O'Dwyer, S A King, C L Fortner, et al.
American Journal of Hospital Pharmacy|March 1, 1972
Postadmission drug and allergy histories recorded by a pharmacistJ C Cradock, G R Whitfield, J W Menzie, et al.
Cancer|February 1, 1976
Cost analysis of leukemia treatment: a problem-oriented approachR J Esterhay, V G Vogel, C L Fortner, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Drug Intelligence & Clinical Pharmacy|May 1, 1985
Cisplatin nephrotoxicity: a summary of preventative interventionsR S Finley, C L Fortner, W R Grove
American Journal of Hospital Pharmacy|September 1, 1977
High-dose methotrexate with folinic acid rescueJ F Bender, W R Grove, C L Fortner
American Journal of Hospital Pharmacy|June 1, 1975
Fat emulsion vehicle for intravenous administration of an aqueous insoluble drugC L Fortner, W R Grove, D Bowie, et al.
Archives of Internal Medicine|April 1, 1980
Meperidine for the treatment of shaking chills and feverL C Burks, J Aisner, C L Fortner, et al.
Clinical Pharmacy|July 1, 1982
Rifampin and cloxacillin in the reduction of Staphylococcus aureus colonizationR S Finley, S C Schimpff, C L Fortner, et al.
Journal of the American Pharmaceutical Association|January 1, 1973
Allopurinol-mercaptopurine interactionA M Weissman, D G Christian, W A Cornelis, et al.
The Journal of Infectious Diseases|December 1, 1974
Cytosine arabinoside for localized herpes zoster in patients with cancer: failure in a controlled trialS C Schimpff, C L Fortner, W H Greene, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Hypersensitivity reactions to teniposide (VM-26): an analysisP J O'Dwyer, S A King, C L Fortner, et al.
American Journal of Hospital Pharmacy|March 1, 1972
Postadmission drug and allergy histories recorded by a pharmacistJ C Cradock, G R Whitfield, J W Menzie, et al.
Cancer|February 1, 1976
Cost analysis of leukemia treatment: a problem-oriented approachR J Esterhay, V G Vogel, C L Fortner, et al.
Pageof 4